Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Jaffe

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
BMJ (Clinical Research Ed.)|June 30, 2007
Time to move towards opt-out testing for HIV in the UKM Hamill, K Burgoine, F Farrell, et al.
JAMA|August 3, 1984
Unexplained immunodeficiency in children. A surveillance reportP A Thomas, H W Jaffe, T J Spira, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1982
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococciH W Jaffe, H M Sweeney, R A Weinstein, et al.
Archives of Internal Medicine|February 1, 1978
Tests for treponemal antibody in CSFH W Jaffe, S A Larsen, M Peters, et al.
The Journal of Infectious Diseases|March 1, 1982
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmidsR A Weinstein, S A Kabins, C Nathan, et al.
Lancet (London, England)|March 14, 1992
Kaposi's sarcoma and exposure to faecesW W Darrow, T A Peterman, H W Jaffe, et al.
Science (New York, N.Y.)|June 28, 1996
HIV-2 and natural protection against HIV-1 infectionA E Greenberg, S Z Wiktor, K M DeCock, et al.
The New England Journal of Medicine|January 1, 1976
National gonorrhea therapy monitoring study: treatment resultsR E Kaufman, R E Johnson, H W Jaffe, et al.
Science (New York, N.Y.)|June 28, 1996
HIV-2 and Natural Protection Against HIV-1 InfectionA E Greenberg, S Z Wiktor, K M Decock, et al.
Science (New York, N.Y.)|September 27, 1985
The epidemiology of AIDS: current status and future prospectsJ W Curran, W M Morgan, A M Hardy, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|June 30, 2007
Time to move towards opt-out testing for HIV in the UKM Hamill, K Burgoine, F Farrell, et al.
JAMA|August 3, 1984
Unexplained immunodeficiency in children. A surveillance reportP A Thomas, H W Jaffe, T J Spira, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1982
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococciH W Jaffe, H M Sweeney, R A Weinstein, et al.
Archives of Internal Medicine|February 1, 1978
Tests for treponemal antibody in CSFH W Jaffe, S A Larsen, M Peters, et al.
The Journal of Infectious Diseases|March 1, 1982
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmidsR A Weinstein, S A Kabins, C Nathan, et al.
Lancet (London, England)|March 14, 1992
Kaposi's sarcoma and exposure to faecesW W Darrow, T A Peterman, H W Jaffe, et al.
Science (New York, N.Y.)|June 28, 1996
HIV-2 and natural protection against HIV-1 infectionA E Greenberg, S Z Wiktor, K M DeCock, et al.
The New England Journal of Medicine|January 1, 1976
National gonorrhea therapy monitoring study: treatment resultsR E Kaufman, R E Johnson, H W Jaffe, et al.
Science (New York, N.Y.)|June 28, 1996
HIV-2 and Natural Protection Against HIV-1 InfectionA E Greenberg, S Z Wiktor, K M Decock, et al.
Science (New York, N.Y.)|September 27, 1985
The epidemiology of AIDS: current status and future prospectsJ W Curran, W M Morgan, A M Hardy, et al.
Pageof 11